Neuregulin signaling at the neuromuscular synapse
Neuregulin signaling at the neuromuscular synapse
批准号:
6896741
负责人:
LARRY B FROMM
金额:
$4.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-15 至 2006-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Synapse formation between a developing axon and its target involves the coordinated differentiation of the pre- and postsynaptic components that mediate synaptic transmission. At developing neuromuscular synapses, acetylcholine receptors (AChRs) are among the proteins that become localized to the postsynaptic region in muscle, and their localization to this small patch of the myofiber membrane during development is a hallmark of the inductive events of synapse formation. It is believed that the localization of AChRs is mediated in part by transcriptional mechanisms because the genes encoding AChR subunits are transcribed selectively in the few muscle nuclei that are situated at synaptic sites. Neuregulins (NRGs) are the best candidates for ligands that stimulate synapse-specific gene expression, because NRGs are concentrated at synaptic sites and can induce AChR synthesis in cultured muscle cells. NRG-1-induced AChR transcription requires two transcriptional regulatory elements, one that binds GA-binding protein (GABP), a heterodimer of the Ets protein GABP alpha and GABP beta, and another that binds Sp1, a zinc finger protein. The proposed research addresses the mechanisms by which NRGs signal through GABP and Sp1 to mediate a transcriptional response. The specific aims are to determine if GABP is required for NRG-l-induced transcription; determine if NRG-1-stimulated phosphorylation of GABP alpha is critical for inducing transcription; determine if a transcriptional activation domain of GABP beta is required for inducing transcription in response to NRG-1; identify the region of Sp1 that is sufficient for regulating DNA binding in response to NRG-1. In addition to providing information on development of the neuromuscular synapse, the proposed experiments may also yield insight into other processes which are influenced by neuregulin signaling, such as cellular transformation
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Sensory innervation-dependent transcriptional regulation in muscle
-
批准号:8036715
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2010
-
负责人:LARRY B FROMM
-
依托单位:
Chromatin modifications that regulate transcription at the neuromuscular synapse
-
批准号:7012395
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2006
-
负责人:LARRY B FROMM
-
依托单位:
Neuregulin signaling at the neuromuscular synapse
-
批准号:6666091
-
项目类别:
-
资助金额:$14.3万
-
财政年份:2003
-
负责人:LARRY B FROMM
-
依托单位:
NEUREGULIN SIGNALING AT THE NEUROMUSCULAR SYNAPSE
-
批准号:2865293
-
项目类别:
-
资助金额:$3.84万
-
财政年份:1999
-
负责人:LARRY B FROMM
-
依托单位:
NEUREGULIN SIGNALLING AT THE NEUROMUSCULAR SYNAPSE
-
批准号:2036875
-
项目类别:
-
资助金额:$2.37万
-
财政年份:1997
-
负责人:LARRY B FROMM
-
依托单位:
NEUREGULIN SIGNALLING AT THE NEUROMUSCULAR SYNAPSE
-
批准号:2591723
-
项目类别:
-
资助金额:$3.02万
-
财政年份:1997
-
负责人:LARRY B FROMM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
GASP-1通过Myostatin信号通路调控颏舌肌功能的作用及机制研究
-
批准号:82371131
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:易红良
-
依托单位:
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
-
批准号:82370684
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅强
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
PCBP1和PCBP2调控cGAS的相变和酶活的机制研究
-
批准号:32370928
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:孙钦秒
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: